Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
TauRx Announces Results from Phase 3 Alzheimer's Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions 2022-10-06 18:00
Cytiva strengthens cell line development with CEVEC acquisition 2022-10-06 14:00
Servier unveils its 2030 ambition and reveals a new visual identity 2022-10-06 13:30
ASTRAZENECA, First Organization in Egypt receiving Best place to work for Millennials Award 2022-10-05 22:59
Ascletis Announces Dosing of the First Patient in Phase II Clinical Trial of THRβ Agonist ASC41 for 52-Week Treatment of Liver Biopsy-Proven NASH 2022-10-05 08:10
Transcenta Received IND Clearance from FDA for Its Best-In-Class MASP2 Targeting Antibody TST004 for the Treatment of IgA Nephropathy 2022-10-05 08:00
HAVAS HEALTH & YOU APPOINTS PAUL PFLEIDERER AS PRESIDENT OF HAVAS LIFE NEW YORK 2022-10-04 21:00
HanAll's Second FcRn Inhibitor HL161ANS to be Added to the Development Program of its Licensed Partner 2022-10-04 19:00
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry 2022-10-04 14:00
DEBIOPHARM REINFORCES THE BOND BETWEEN SWISS AND JAPANESE CANCER RESEARCH WITH THE 2022 JCA MAUVERNAY AWARD CEREMONY 2022-10-03 15:00
AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease 2022-10-03 09:00
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022 2022-10-01 04:30
Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023 2022-10-01 00:53
YS BIOPHARMA TO MERGE WITH NASDAQ-LISTED SUMMIT HEALTHCARE ACQUISITION CORP. 2022-09-30 04:01
First Patient in New Zealand Dosed with Illuccix® - Telix's Prostate Cancer Imaging Agent 2022-09-30 02:30
Doxy.me extends telemedicine's reach to 88% of the world's population 2022-09-29 22:03
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™ at BPI Boston 2022 2022-09-29 19:00
NeuShen Therapeutics Closes Pre-A Financing with ~$20M 2022-09-29 17:50
Kintor Pharma Announces Publication of Phase Ib Data from Pruxelutamide for AR+ mBC in EJC 2022-09-29 14:22
Simcere and Almirall Enter into a Licensing Agreement for IL-2 mu-Fc 2022-09-29 11:32
1 111 112 113 114 115 377